INSTRUMENT No 5 OF 1996
VETERANS' ENTITLEMENTS ACT 1986
EXPLANATORY NOTES FOR TABLING
The Minister has approved, under sub-section 91(3) of the Veterans'
Entitlements Act 1986 (the Act), and effective from 1 February 1997, the attached Instrument Number 5 of 1996. The instrument varies the Veterans'
Affairs Pharmaceutical Benefits Scheme under sub-section 91(2) of the Act,
and is prepared by the Repatriation Commission under sub-section 91(2) of the
Act.
The variations to the Instrument are required to make clear that the Veterans'
Affairs Pharmaceutical Benefits Scheme (VAPBS) is consistent with the amended Explanatory Notes published in the Schedule of Pharmaceutical
Benefits for Approved Pharmacists and Medical Practitioners under the
National Health Act 1953.
Overview
The Veterans' Entitlements Act 1986, enacted by the Australian Parliament, was established to address the need for a comprehensive and supportive framework for the healthcare and pharmaceutical needs of veterans and their families. The Act was designed to ensure that veterans receive the necessary medical and pharmaceutical benefits to support their health and wellbeing, which is crucial given their service to the nation. One of the key instruments under this Act is Instrument Number 5 of 1996, which was approved by the Minister and came into effect on 1 February 1997. This instrument, prepared by the Repatriation Commission, varies the Veterans' Affairs Pharmaceutical Benefits Scheme to align it with the amended Explanatory Notes published in the Schedule of Pharmaceutical Benefits under the National Health Act 1953. The policy objective of these variations is to ensure that the Veterans' Affairs Pharmaceutical Benefits Scheme operates smoothly and in accordance with the latest national health guidelines, thereby providing consistent and updated pharmaceutical benefits to veterans.
Scope and Application
The Veterans' Entitlements Act 1986 applies to veterans, their dependants, and certain other individuals who have served in the Australian Defence Force. The Act aims to provide various benefits and services to eligible persons, including healthcare benefits administered through the Veterans' Affairs Pharmaceutical Benefits Scheme (VAPBS). The Act operates within the Commonwealth jurisdiction and applies nationally, as it is a federal statute. The variations made through Instrument Number 5 of 1996, effective from 1 February 1997, ensure that the VAPBS aligns with the amended Explanatory Notes published in the Schedule of Pharmaceutical Benefits under the National Health Act 1953. This alignment ensures that the pharmaceutical benefits provided to veterans and their dependants are consistent with national standards and regulations. The instrument does not specify any exclusions or exemptions, but the scope of its application is determined by the eligibility criteria set out in the Veterans' Entitlements Act 1986. The Act may be further extended or restricted through subordinate instruments, as necessary, to adapt to changes in national health policies and pharmaceutical practices.
Key Provisions
The main operative sections of this instrument (Instrument No 5 of 1996) pertain to the Veterans' Affairs Pharmaceutical Benefits Scheme (VAPBS) as outlined in sections 91(2) and 91(3) of the Veterans' Entitlements Act 1986. This instrument modifies the VAPBS to ensure its alignment with the amended Explanatory Notes published in the Schedule of Pharmaceutical Benefits under the National Health Act 1953. Essentially, it seeks to update the VAPBS to reflect any changes in the national pharmaceutical schedule, thereby ensuring that veterans receive pharmaceutical benefits that are consistent with those available to the general public.
The obligations and requirements imposed by this instrument on the parties involved, primarily the Repatriation Commission, include the responsibility to prepare and approve the variations to the VAPBS. This involves ensuring that the VAPBS accurately reflects the latest amendments to the Schedule of Pharmaceutical Benefits, thereby maintaining parity in pharmaceutical entitlements between veterans and the broader population. Additionally, the Repatriation Commission must ensure that all updates and changes are communicated effectively to relevant stakeholders, including pharmacists, medical practitioners, and veterans, to ensure smooth implementation and compliance with the updated scheme.
In terms of legal consequences for non-compliance with the provisions of this instrument, it is essential to note that the Veterans' Entitlements Act 1986 does not explicitly outline specific offences, penalties, or civil/criminal consequences in the context of this instrument. However, any failure to adhere to the updated VAPBS as required by this instrument could potentially result in administrative penalties, such as fines or other enforcement actions, depending on the nature and extent of the non-compliance. Furthermore, any actions that result in veterans not receiving their entitled pharmaceutical benefits could be subject to review and potential corrective measures by relevant authorities. It is therefore crucial for all parties involved to ensure strict compliance with the updated VAPBS to avoid any potential repercussions.